Tavo Biotherapeutics Appoints Lukas Scheibler as Chief R&D Officer and Graham Cooper as Chief Financial Officer
Position
Chief Financial Officer
Company
Tavo Biotherapeutics
MemphisBiotechnologyHealth CareTherapeuticsDescription
Tavo Biotherapeutics announces the appointment of Lukas Scheibler, Ph.D. as Chief Research and Development Officer, and Graham Cooper as Chief Financial Officer. Both executives bring extensive experience in the biotechnology industry, positioned to drive Tavo's strategic initiatives.
Quick answer
Tavo Biotherapeutics Appoints Lukas Scheibler as Chief R&D Officer and Graham Cooper as Chief Financial Officer (April 29, 2025). Tavo Biotherapeutics is based in Memphis, Tennessee, United States.
- Who is the new Chief Financial Officer at Tavo Biotherapeutics?
- Tavo Biotherapeutics named Graham Cooper Chief Financial Officer, announced April 29, 2025.
- What did Tavo Biotherapeutics announce on April 29, 2025?
- Tavo Biotherapeutics announces the appointment of Lukas Scheibler, Ph.D. as Chief Research and Development Officer, and Graham Cooper as Chief Financial Officer. Both executives bring extensive experience in the biotechnology industry, positioned to drive Tavo's strategic initiatives.
- What does Tavo Biotherapeutics do?
- Tavo Biotherapeutics is developing innovative treatments to address critical unmet needs in ophthalmology.
- Where is Tavo Biotherapeutics based?
- Tavo Biotherapeutics is based in Memphis, Tennessee, United States.
- Which similar companies made leadership changes around the same time?
- AAVantgarde Bio (April 28, 2025), Enara Bio (May 1, 2025), Eccogene (May 1, 2025) and Hansa Biopharma (April 24, 2025) also announced leadership changes within 45 days of Tavo Biotherapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AAVantgarde Appoints Rasmus Holm-Jorgensen as Chief Financial Officer (April 28, 2025)
- Enara Bio Appoints Stacey Davis as Chief Business Officer and CFO (May 1, 2025)
- Eccogene Appoints Jai Patel as Chief Medical Officer (May 1, 2025)
- Hansa Biopharma Appoints Renée Aguiar-Lucander as Chief Executive Officer (April 24, 2025)
- BioNTech Appoints Ramón Zapata as Chief Financial Officer (May 5, 2025)
- Priothera Appoints Jens Hasskarl as Chief Medical Officer (May 6, 2025)
Who to call at Tavo Biotherapeutics, and when
A new leader at Tavo Biotherapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Tavo Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tavo Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tavo Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tavo Biotherapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Tavo Biotherapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.